Windlas Biotech Ltd - Prospectus Synopsis

Windlas Biotech Ltd pdf Icon RHP

Registered Office : 40/1 Mohabewala Industrial , Area , Dehradun - 248110 , Uttarakhand , India.

Phone : 91-135-6608000  Fax :

Email :grievance@windlasbiotech.com    Website : www.windlasbiotech.com

Initial Public Offer of 8,729,023* equity shares of face value of Rs.5 each (equity shares) of Windlas Biotech Limited (company Rs.455 per equity share) aggregating to Rs.401.54 Crores (the offer) comprising a fresh issue of 3,586,956* equity shares aggregating to Rs.165 Crores (the fresh issue) and an offer for sale of 5,142,067* equity shares, comprising of 1,136,000* equity shares aggregating to Rs.52.26* Crores by Vimla Windlass (the individual selling shareholder) and 4,006,067* equity shares aggregating to Rs.184.28* Crores by Tano India Private Equity Fund II (the investor selling shareholder, and collectively with the individual selling shareholder, the selling shareholders, and such equity shares, the offered shares) aggregating to Rs.236.54 Crores (the offer for sale). The offer constitutes 40.05% of the post-offer paid-up equity share capital of the Company. The face value of equity shares is Rs.5 each. The offer price is Rs.460 per equity share and is 92 times the face value of the equity shares. *subject to finalisation of the basis of allotment.

IssueMoney Payable On
Opens OnCloses OnApplicationAllotment
8/4/2021 12:00:00 AM 8/6/2021 12:00:00 AM Rs 460 - 0Rs 0 - 0
Minimum Application for shares in Nos : 30 Further Multiples of : 30
 Rs CrLead Managers to the Issue
Project Cost 165 DAM Capital Advisors Ltd
Project Financed through Current Offer 401.54  
Post Issue Equity Share Capital 165  
Issue PriceRs. 460 
Projects
Purchase of Equipment required for (i) Capacity Expansion of the existing facility at the Dehradun Plant-IV and (II) Addition of Injectables Dosage Capability at the existing facility at Dehradun Plant - II
Promoted ByListing AtRegistrar to the Issue
Ashok Kumar Windlass
Hitesh Windlass
Manoj Kumar Windlass
- Link Intime India Pvt Ltd